Commensurate with this association is the increased expression of a key cytotoxic drug transporter, MRP2, which may have a role in the response of CRC to frontline drugs, Oxaliplatin, 5-Flurouracil and Camptothecin. Here, ABCC2 is linked to colorectal carcinoma.